Cardinal Health, Inc. which can be found using ticker (CAH) have now 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $133.00 and $96.00 suggesting an average analyst share price target price of $115.29. (at the time of writing). Given that the stocks previous close was at $115.48 this indicates there is a potential downside of -.2%. The 50 day MA is $106.91 and the 200 moving average now moves to $96.96. The company has a market cap of 28.12B. The stock price for the company is currently is currently $115.62 USD
The potential market cap would be $28,076,329,127 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 45.88, revenue per share of $859.44 and a 2.79% return on assets.
Cardinal Health, Inc. is a globally integrated healthcare services and products company. The Company is focused on providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and solutions. The Company’s segments include Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and patient management.
